Ascletis Pharma-B (01672.HK) grants 1.8 million share options

Zhitong Finance APP News, Ascletis Pharma-B (01672.HK) announced that on November 4, 2026, the Company granted share options to 42 participants to subscribe for a total of 1.8 million ordinary shares of the Company with a par value of US$0.0001 per share. The exercise price of the granted share options is HK$4.923 per share, with a validity period of 10 years.